Frederick "Rick" Jones
Frederick “Rick” Jones, M.D., M.B.A. is a Partner. Dr. Jones has over 30 years in the life science industries, serving in roles as physician, executive, consultant, director and investor. At BioAdvance he is responsible for investments in therapeutics and medical devices and serves on the Board of MNI.
Previously Dr. Jones was a Director at Broadview Ventures, a Boston-based philanthropic venture fund focused on breakthrough technologies in cardiovascular disease. At Broadview Ventures, Dr. Jones has served as Director on the board of Aeromics and Nido Surgical, and as Observer on the boards of Aria CV, Ischemia Care and Remedy Pharmaceuticals. Prior to Broadview Dr. Jones served as CEO of Anchor Therapeutics, a venture-backed company, which was developing a platform based on peptide modulators of GPCRs. Prior to Anchor, Dr. Jones held executive positions with Devgen NV (Ghent, Belgium) and BioRexis (acquired by Pfizer). Dr. Jones began his industry career at Wyeth Pharmaceuticals, initially in Global Medical Affairs and subsequently in Global Business Development.
Dr. Jones is a board-certified internal medicine physician who practiced in the US Navy, the Lahey Clinic (Burlington, MA) and at the University of Pennsylvania. He received his BA, MD and MBA degrees from the University of Pennsylvania.